Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic Mix

by palligoelme@gmail.com | Sep 19, 2025 | Clinical Trials

​ Conditions: HIV Infections Interventions: Biological: HIV Therapeutic Biologic Mix – HIV GP120 plus HIV GP41 plus BCG Vaccine Mix for percutaneous use Sponsors: Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair; UnitedHealthcare Active, not...

Pre-infusion Aerobic Cycling Exercise for CardioRespiratory Fitness in Cancer Patients

by palligoelme@gmail.com | Sep 19, 2025 | Clinical Trials

​ Conditions: Cancer Interventions: Behavioral: Exercise Sponsors: University of Dublin, Trinity College Not yet recruiting Conditions: Cancer Interventions: Behavioral: Exercise Sponsors: University of Dublin, Trinity College Not yet...

Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers

by palligoelme@gmail.com | Sep 18, 2025 | Clinical Trials

​ Conditions: Healthy Interventions: Drug: JLP-2302; Drug: JP-1366 Sponsors: Onconic Therapeutics Inc. Completed Conditions: Healthy Interventions: Drug: JLP-2302; Drug: JP-1366 Sponsors: Onconic Therapeutics Inc....

Trastuzumab Deruxtecan in Advanced Breast Cancer

by palligoelme@gmail.com | Sep 18, 2025 | Clinical Trials

​ Conditions: Advanced Breast Cancer Interventions: Drug: Trastuzumab deruxtecan Sponsors: Wenjin Yin Not yet recruiting Conditions: Advanced Breast Cancer Interventions: Drug: Trastuzumab deruxtecan Sponsors: Wenjin Yin Not yet...

High-Frequency vs. Theta-Burst TMS for Depression: Double-Blind RCT

by palligoelme@gmail.com | Sep 18, 2025 | Clinical Trials

​ Conditions: Major Depression Interventions: Device: High-frequency repetitive transcranial magnetic stimulation; Device: Intermittent Theta Burst Stimulation Sponsors: Krajská zdravotní, a.s. – Nemocnice Most, o.z. Completed Conditions: Major Depression...